Plasma rich in growth factors (PRGF ‐ENDORET®) to rescue necrotized orbital dermis‐fat grafts

Purpose

To report the clinical course of three patients treated with topical plasma rich in growth factors (PRGF) to rescue Dermal-fat grafts (DFG) with graft ulceration (GU).

Methods

Retrospective, case-series study of three patients diagnosed with GU in DFG and treated with PRGF. Drops were applied 4 times per day and treatment was maintained until the GU resolved. Data were collected from medical records and anterior segment photos.

Results

All patients showed a favorable response to topical PRGF having accomplished full resolution of the GU within a mean of 30 days of treatment (range: 21–35 days). During the full extent of follow-up, no side-effects, signs of rejection or necrosis were reported and every patient was pleased with the final aesthetic result.

Conclusions

Our results suggest that PRGF could be an effective treatment for dermal graft ulceration in patients who underwent DFG surgery/implantation, mainly due to its low morbidity when compared to traditional procedures.

Comments (0)

No login
gif